Cash flow Cizzle Biotechnology Holdings Plc

Equities

PSL

GB00BNG2VN02

Biotechnology & Medical Research

Market Closed - London S.E. Other stock markets 10:05:27 13/02/2026 pm IST			5-day change	1st Jan Change
1.350 ^GBX	-12.90%		-12.90%	-12.90%

04/02	Cizzle secures Canadian patent for lung cancer test format	AN
04/02	Cizzle Biotechnology Lung Cancer Test Secures Patent in Canada	MT

91f.oimkxrbIkWss7WjnLneyvy6-xmZ6t9W6tYD-vKi4HAc.7n_Bv9iqpzsfvDGlHzrD-3qKpzMP1OPs4fi45fyLLj_OWomx7pz_DWq1Gw

Published financial data: CIZZLE BIOTECHNOLOGY HOLDINGS PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	-	-	-	-	-
Total Revenues	-	-	-	-	-
Cost of Goods Sold, Total	-	-	-	-	-
Gross Profit	-	-	-	-	-
Selling General & Admin Expenses, Total	14T	6L	10L	10L	9L
R&D Expenses	-	2L	-	-	-
Other Operating Expenses	-	-	-	-	-
Other Operating Expenses, Total	14T	8L	10L	10L	9L
Operating Income	-14T	-8L	-10L	-10L	-9L
Interest And Investment Income	-	-	-	-	-
Net Interest Expenses	-	-	-	-	-
Other Non Operating Income (Expenses)	-	-53T	-	-	80T
EBT, Excl. Unusual Items	-14T	-9L	-10L	-10L	-8L
Merger & Related Restructuring Charges	-	-31.07L	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-	-7L	-13.91L
Gain (Loss) On Sale Of Assets	-	-	-	44T	-
Other Unusual Items	-	-	-	-1L	-
EBT, Incl. Unusual Items	-14T	-39.58L	-10L	-17.63L	-21.87L
Income Tax Expense	-	-37T	-51T	-46T	-21T
Earnings From Continuing Operations	-14T	-39.21L	-9L	-17.17L	-21.66L
Net Income to Company	-14T	-39.21L	-9L	-17.17L	-21.66L
Net Income - (IS)	-14T	-39.21L	-9L	-17.17L	-21.66L
Net Income to Common Incl Extra Items	-14T	-39.21L	-9L	-17.17L	-21.66L
Net Income to Common Excl. Extra Items	-14T	-39.21L	-9L	-17.17L	-21.66L
Per Share Items
Net EPS - Basic	-0.03	-0.02	-0	-0	-0.01
Basic EPS - Continuing Operations	-0.03	-0.02	-0	-0	-0.01
Basic Weighted Average Shares Outstanding	5L	16Cr	29Cr	36Cr	39Cr
Net EPS - Diluted	-0.03	-0.02	-0	-0	-0.01
Diluted EPS - Continuing Operations	-0.03	-0.02	-0	-0	-0.01
Diluted Weighted Average Shares Outstanding	5L	16Cr	29Cr	36Cr	39Cr
Normalized Basic EPS	-0.02	-0	-0	-0	-0
Normalized Diluted EPS	-0.02	-0	-0	-0	-0
Supplemental Items
EBITDA	-	-	-	-	-
EBITA	-14T	-8L	-10L	-10L	-9L
EBIT	-14T	-8L	-10L	-10L	-9L
Effective Tax Rate - (Ratio)	-	0.93	5.3	2.61	0.96
Total Current Taxes	-	-	-	-	-
Normalized Net Income	-8.75T	-5L	-6L	-6L	-5L
Supplemental Operating Expense Items
General and Administrative Expenses	14T	5L	10L	10L	9L
Research And Development Expense From Footnotes	-	2L	3L	2L	2L
Stock-Based Comp., G&A Exp. (Total)	-	31.4L	1L	3L	2L
Total Stock-Based Compensation	-	31.4L	1L	3L	2L

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	7T	9L	5L	1L	4L
Trading Asset Securities, Total	-	-	-	14.13L	22T
Total Cash And Short Term Investments	7T	9L	5L	15.57L	4L
Other Receivables	-	51T	95T	1L	76T
Total Receivables	-	51T	95T	1L	76T
Inventory	-	-	-	-	2T
Prepaid Expenses	3T	29T	12T	27T	27T
Other Current Assets, Total	-	-	1L	-	-
Total Current Assets	10T	10L	7L	16.93L	5L
Gross Property Plant And Equipment	-	-	-	-	-
Accumulated Depreciation	-	-	-	-	-
Net Property Plant And Equipment	-	-	-	-	-
Long-term Investments	-	-	-	-	-
Other Intangibles, Total	-	2L	20.8L	-	-
Total Assets	10T	11.55L	27.85L	16.93L	5L
Liabilities
Accounts Payable, Total	2T	1L	41T	92T	13T
Accrued Expenses, Total	6T	1L	1L	94T	4L
Short-term Borrowings	10T	-	-	-	-
Unearned Revenue Current, Total	-	-	-	-	-
Total Current Liabilities	18T	2L	1L	2L	4L
Unearned Revenue Non Current	-	-	-	-	-
Total Liabilities	18T	2L	1L	2L	4L
Common Stock, Total	3T	34.93L	35.02L	35.04L	35.07L
Additional Paid In Capital	15.85L	3.26Cr	3.49Cr	3.53Cr	3.59Cr
Retained Earnings	-15.96L	-55.17L	-61.53L	-78.7L	-1Cr
Comprehensive Income and Other	-	-2.96Cr	-2.96Cr	-2.95Cr	-2.93Cr
Total Common Equity	-8T	9L	26.4L	15.07L	82T
Total Equity	-8T	9L	26.4L	15.07L	82T
Total Liabilities And Equity	10T	11.55L	27.85L	16.93L	5L
Supplemental Items
ECS Total Shares Outstanding on Filing Date	5L	25Cr	34Cr	36Cr	40Cr
ECS Total Common Shares Outstanding	5L	25Cr	34Cr	36Cr	40Cr
Book Value / Share	-0.02	0	0.01	0	0
Tangible Book Value	-8T	7L	6L	15.07L	82T
Tangible Book Value Per Share	-0.02	0	0	0	0
Total Debt	10T	0	0	0	0
Net Debt	3T	-9L	-5L	-15.57L	-4L
Account Code - Inventory Valuation	-	3	3	3	3
Machinery, Total	-	-	-	-	-
Full Time Employees	-	4	4	4	4

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-14T	-39.21L	-9L	-17.17L	-21.66L
Amortization of Deferred Charges, Total - (CF)	-	32T	-	-	-
(Gain) Loss From Sale Of Asset	-	-	-	-44T	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	7L	13.91L
Stock-Based Compensation (CF)	-	3L	1L	3L	2L
Other Operating Activities, Total	-	27.67L	-51T	1L	24T
Change In Accounts Receivable	-	7T	16T	-24T	6T
Change In Accounts Payable	-2T	-2L	-73T	13T	2L
Cash from Operations	-16T	-10.09L	-9L	-6L	-4L
Cash Acquisitions	-	46T	-	-	-
Sale (Purchase) of Intangible assets	-	-2L	-	-	-
Other Investing Activities, Total	-	-	-1L	-	-
Cash from Investing	-	-2L	-1L	-	-
Short Term Debt Issued, Total	10T	-	-	-	-
Total Debt Issued	10T	-	-	-	-
Short Term Debt Repaid, Total	-	-10T	-	-	-
Total Debt Repaid	-	-10T	-	-	-
Issuance of Common Stock	-	22L	7L	4L	7L
Other Financing Activities, Total	-	-2L	-80T	-45T	-72T
Cash from Financing	10T	20.31L	6L	3L	6L
Net Change in Cash	-6T	9L	-4L	-3L	2L
Supplemental Items
Cash Income Tax Paid (Refund)	-	-	-	-41T	-46T
Levered Free Cash Flow	-9.94T	26.06L	-7L	-2L	-1L
Unlevered Free Cash Flow	-9.94T	26.06L	-7L	-2L	-1L
Change In Net Working Capital	1.19T	-1L	2L	-1L	-3L
Net Debt Issued / Repaid	10T	-10T	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-66.1	-85.62	-30.55	-27.24	-50.11
Return on Total Capital	-202.78	-106.23	-33.65	-29.42	-68.91
Return On Equity %	2.05T	-844.13	-50.99	-82.81	-272.62
Return on Common Equity	2.05T	-844.13	-50.99	-82.81	-272.62
Margin Analysis
Gross Profit Margin %	-	-	-	-	-
SG&A Margin	-	-	-	-	-
EBITDA Margin %	-	-	-	-	-
EBITA Margin %	-	-	-	-	-
EBIT Margin %	-	-	-	-	-
Income From Continuing Operations Margin %	-	-	-	-	-
Net Income Margin %	-	-	-	-	-
Net Avail. For Common Margin %	-	-	-	-	-
Normalized Net Income Margin	-	-	-	-	-
Asset Turnover
Asset Turnover	-	-	-	-	-
Fixed Assets Turnover	-	-	-	-	-
Short Term Liquidity
Current Ratio	0.56	4.38	4.86	9.1	1.2
Quick Ratio	0.39	4.25	3.95	8.96	1.13
Operating Cash Flow to Current Liabilities	-0.89	-4.63	-6.01	-3.44	-0.87
Average Days Payable Outstanding	-	-	-	-	-
Long Term Solvency
Total Debt/Equity	-125	-	-	-	-
Total Debt / Total Capital	500	-	-	-	-
Total Liabilities / Total Assets	180	18.87	5.21	10.99	83.33
Net Debt / EBITDA	-	-	-	-	-
Net Debt / (EBITDA - Capex)	-	-	-	-	-
Growth Over Prior Year
Gross Profit, 1 Yr. Growth %	-	-	-	-	-
EBITDA, 1 Yr. Growth %	-	-	-	-	-
EBITA, 1 Yr. Growth %	-35.51	5.6T	13.16	1.35	-10.25
EBIT, 1 Yr. Growth %	-35.51	5.6T	13.16	1.35	-10.25
Earnings From Cont. Operations, 1 Yr. Growth %	-35.51	27.91T	-76.74	88.27	26.15
Net Income, 1 Yr. Growth %	-35.51	27.91T	-76.74	88.27	26.15
Normalized Net Income, 1 Yr. Growth %	-35.51	5.98T	13.16	1.35	-18.44
Diluted EPS Before Extra, 1 Yr. Growth %	-59	-13.83	-87.19	54.12	15.88
Net Property, Plant and Equip., 1 Yr. Growth %	-	-	-	-	-
Total Assets, 1 Yr. Growth %	-39.31	11.45T	141.13	-39.21	-70.94
Tangible Book Value, 1 Yr. Growth %	-220.65	-9.31T	-24.02	169.11	-94.56
Common Equity, 1 Yr. Growth %	-220.65	-11.81T	181.75	-42.92	-94.56
Cash From Operations, 1 Yr. Growth %	126.24	6.21T	-13.58	-26.72	-43.98
Levered Free Cash Flow, 1 Yr. Growth %	-1.03T	-26.33T	-126.19	-74.62	-39.47
Unlevered Free Cash Flow, 1 Yr. Growth %	-1.03T	-26.33T	-126.19	-74.62	-39.47
Compound Annual Growth Rate Over Two Years
Gross Profit, 2 Yr. CAGR %	-	-	-	-	-
EBITDA, 2 Yr. CAGR %	-	-	-	-	-
EBITA, 2 Yr. CAGR %	120.02	506.28	729.37	7.09	-4.62
EBIT, 2 Yr. CAGR %	120.02	506.28	729.37	7.09	-4.62
Earnings From Cont. Operations, 2 Yr. CAGR %	120.25	1.24T	707.11	-33.83	54.11
Net Income, 2 Yr. CAGR %	120.25	1.24T	707.11	-33.83	54.11
Normalized Net Income, 2 Yr. CAGR %	120.3	526.1	729.37	7.09	-9.08
Diluted EPS Before Extra, 2 Yr. CAGR %	75.61	-40.56	-66.77	-55.56	33.64
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	-	-	-
Total Assets, 2 Yr. CAGR %	-54.85	737.24	1.57T	21.07	-57.97
Tangible Book Value, 2 Yr. CAGR %	-46.87	954.25	736.66	43	-61.73
Common Equity, 2 Yr. CAGR %	-46.87	1.09T	1.72T	26.82	-82.38
Cash From Operations, 2 Yr. CAGR %	56.1	1.09T	638.24	-20.42	-35.93
Levered Free Cash Flow, 2 Yr. CAGR %	14.01	4.84T	723.54	-74.22	-60.81
Unlevered Free Cash Flow, 2 Yr. CAGR %	14.01	4.84T	723.54	-74.22	-60.81
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	-	-
Gross Profit, 3 Yr. CAGR %	-	-	-	-	-
EBITDA, 3 Yr. CAGR %	-	-	-	-	-
EBITA, 3 Yr. CAGR %	-53.57	551.03	253.99	311.57	0.97
EBIT, 3 Yr. CAGR %	-53.57	551.03	253.99	311.57	0.97
Earnings From Cont. Operations, 3 Yr. CAGR %	-50.89	1.01T	247.64	396.84	-17.95
Net Income, 3 Yr. CAGR %	-50.89	1.01T	247.64	396.84	-17.95
Normalized Net Income, 3 Yr. CAGR %	-53.57	565.69	253.99	311.57	-2.2
Diluted EPS Before Extra, 3 Yr. CAGR %	-57.77	38.51	-64.36	-44.59	-38.83
Total Assets, 3 Yr. CAGR %	-38.56	186.62	452.9	453.2	-24.76
Tangible Book Value, 3 Yr. CAGR %	-36.49	196.27	338.74	473.25	-51.9
Common Equity, 3 Yr. CAGR %	-36.49	220.96	635.66	473.25	-55.6
Cash From Operations, 3 Yr. CAGR %	-53.41	435.63	397.73	241.82	-29.21
Levered Free Cash Flow, 3 Yr. CAGR %	-56.23	598.61	757.97	158.18	-65.74
Unlevered Free Cash Flow, 3 Yr. CAGR %	-56.23	598.61	757.97	158.18	-65.74
Compound Annual Growth Rate Over Five Years
EBITA, 5 Yr. CAGR %	-41.18	32.68	47.09	220.37	109.49
EBIT, 5 Yr. CAGR %	-41.18	32.68	47.09	220.37	109.49
Earnings From Cont. Operations, 5 Yr. CAGR %	-38.98	89.76	50.48	258.84	151.08
Net Income, 5 Yr. CAGR %	-38.98	89.76	50.48	258.84	151.08
Normalized Net Income, 5 Yr. CAGR %	-41.14	34.42	47.09	220.53	105.52
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-45.49	-61.63	-12.1	-39.53
Total Assets, 5 Yr. CAGR %	-52.02	38.77	130.17	103.05	97.25
Tangible Book Value, 5 Yr. CAGR %	-52.09	36.14	78.13	121.38	65.37
Common Equity, 5 Yr. CAGR %	-52.09	42.84	142.9	121.38	65.37
Cash From Operations, 5 Yr. CAGR %	-	-	40.69	149.83	119.21
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	41.58	86.18	149.66
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	41.58	86.18	149.66